Clinical Trial Update: Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS) [Phase 3]

View source ↗

Summary

Phase III study comparing Panzyga to placebo in pediatric acute-onset neuropsychiatric syndrome has completed, with trial results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute-onset Neuropsychiatric Syndrome
• Pandas

Drugs mentioned

• Panzyga (intravenous immunoglobulin)

Snippet

Sponsor: Octapharma | Conditions: Pediatric Acute-Onset Neuropsychiatric Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2026-01-07